General MedicationsINTRATHECALGeneric
CLOROTEKAL
CHLOROPROCAINE HYDROCHLORIDE
Standard Dose
50MG/5ML (10MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview CLOROTEKAL is listed in Drugs@FDA under application 208791 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CHLOROPROCAINE HYDROCHLORIDE Form and strength SOLUTION;INTRATHECAL - 50MG/5ML (10MG/ML) Sponsor B BRAUN MEDICAL Submission history Latest submission status date: 2017-09-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview CLOROTEKAL is listed in Drugs@FDA under application 208791 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CHLOROPROCAINE HYDROCHLORIDE Form and strength SOLUTION;INTRATHECAL - 50MG/5ML (10MG/ML) Sponsor B BRAUN MEDICAL Submission history Latest submission status date: 2017-09-26 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.